Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
29 October 2021Website:
http://sonendo.comNext earnings report:
08 November 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Fri, 01 Nov 2024 13:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
SONX Latest News
Sonendo, Inc. (OTCQX:SONX) Q2 2024 Earnings Conference Call August 7, 2024 4:30 PM ET Corporate Participants Louisa Smith - IR, Gilmartin Group Bjarne Bergheim - President and Chief Executive Officer John Bostjancic - Chief Financial Officer Conference Call Participants Joe Federico - Stifel Financial Corporation Operator Good afternoon, and welcome to the Sonendo Second Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
Sonendo, Inc. (SONX) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.19 per share a year ago.
Sonendo, Inc. (NYSE:SONX ) Q3 2023 Results Conference Call November 8, 2023 4:30 PM ET Company Participants Louisa Smith - Gilmartin Group Bjarne Bergheim - President & Chief Executive Officer Michael Watts - Chief Financial Officer Conference Call Participants Tom Stephan - Stifel Jason Bednar - Piper Sandler Justin Wang - Morgan Stanley Operator Hello, and welcome to Sonendo's Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
Sonendo (NYSE: SONX ) stock is on the rise Wednesday despite the medical technology company recently receiving a delisting notice. That notice comes from the New York Stock Exchange and has to do with the price of SONX stock.
Sonendo, Inc. (SONX) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.57 per share a year ago.
Sonendo, Inc. (NYSE:SONX ) Q1 2023 Results Conference Call May 9, 2023 4:30 PM ET Company Participants Louisa Smith - Gilmartin Group Bjarne Bergheim - President and CEO Michael Watts - CFO Conference Call Participants Tom Stephan - Stifel Nathan Rich - Goldman Sachs Erin Wright - Morgan Stanley Dan Clark - Bank of America Operator Good afternoon, and welcome to Sonendo's First Quarter Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes.
What type of business is Sonendo?
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. The company was incorporated in 2006 and is headquartered in Laguna Hills, California.
What sector is Sonendo in?
Sonendo is in the Healthcare sector
What industry is Sonendo in?
Sonendo is in the Medical Devices industry
What country is Sonendo from?
Sonendo is headquartered in United States
When did Sonendo go public?
Sonendo initial public offering (IPO) was on 29 October 2021
What is Sonendo website?
https://sonendo.com
Is Sonendo in the S&P 500?
No, Sonendo is not included in the S&P 500 index
Is Sonendo in the NASDAQ 100?
No, Sonendo is not included in the NASDAQ 100 index
Is Sonendo in the Dow Jones?
No, Sonendo is not included in the Dow Jones index
When was Sonendo the previous earnings report?
No data
When does Sonendo earnings report?
The next expected earnings date for Sonendo is 08 November 2024